全文获取类型
收费全文 | 3365篇 |
免费 | 196篇 |
国内免费 | 117篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 106篇 |
妇产科学 | 53篇 |
基础医学 | 466篇 |
口腔科学 | 50篇 |
临床医学 | 341篇 |
内科学 | 994篇 |
皮肤病学 | 76篇 |
神经病学 | 128篇 |
特种医学 | 407篇 |
外国民族医学 | 1篇 |
外科学 | 301篇 |
综合类 | 49篇 |
预防医学 | 250篇 |
眼科学 | 31篇 |
药学 | 253篇 |
中国医学 | 6篇 |
肿瘤学 | 148篇 |
出版年
2023年 | 22篇 |
2022年 | 34篇 |
2021年 | 72篇 |
2020年 | 32篇 |
2019年 | 68篇 |
2018年 | 84篇 |
2017年 | 39篇 |
2016年 | 58篇 |
2015年 | 72篇 |
2014年 | 94篇 |
2013年 | 110篇 |
2012年 | 132篇 |
2011年 | 180篇 |
2010年 | 143篇 |
2009年 | 128篇 |
2008年 | 149篇 |
2007年 | 164篇 |
2006年 | 145篇 |
2005年 | 159篇 |
2004年 | 77篇 |
2003年 | 99篇 |
2002年 | 102篇 |
2001年 | 57篇 |
2000年 | 74篇 |
1999年 | 80篇 |
1998年 | 117篇 |
1997年 | 115篇 |
1996年 | 123篇 |
1995年 | 77篇 |
1994年 | 80篇 |
1993年 | 72篇 |
1992年 | 40篇 |
1991年 | 59篇 |
1990年 | 59篇 |
1989年 | 69篇 |
1988年 | 63篇 |
1987年 | 60篇 |
1986年 | 38篇 |
1985年 | 64篇 |
1984年 | 23篇 |
1983年 | 24篇 |
1982年 | 27篇 |
1981年 | 21篇 |
1980年 | 32篇 |
1979年 | 9篇 |
1978年 | 13篇 |
1977年 | 16篇 |
1976年 | 29篇 |
1975年 | 20篇 |
1967年 | 7篇 |
排序方式: 共有3678条查询结果,搜索用时 0 毫秒
81.
82.
83.
84.
Bonaque JC Pascual-Figal DA Manzano-Fernández S González-Cánovas C Vidal A Muñoz-Esparza C Garrido IP Pastor-Pérez F Valdés M 《Revista espa?ola de cardiología》2012,65(7):606-612
Introduction and objectives
Red blood cell distribution width has emerged as a new prognostic biomarker in cardiovascular diseases. Its additional value in risk stratification of patients with chronic heart failure has not yet been established.Methods
A total of 698 consecutive outpatients with chronic heart failure were studied (median age 71 years [interquartile range, 62-77], 63% male, left ventricular ejection fraction 40 [14]%). On inclusion, the red cell distribution width was measured and clinical, biochemical, and echocardiographic variables were recorded. The median follow-up period was 2.5 years [interquartile range 1.2-3.7].Results
A total of 211 patients died and 206 required hospitalization for decompensated heart failure. Kaplan-Meier analysis showed an increase in the probability of death and hospitalization for heart failure with red cell distribution width quartiles (log rank, P<.001). A ROC analysis identified a red cell distribution width of 15.4% as the optimal cut-off point for a significantly higher risk of death (P<.001; hazard ratio=2.63; 95% confidence interval, 2.01-3.45) and hospitalization for heart failure (P<.001; hazard ratio=2.37; 95% confidence interval, 1.80-3.13). This predictive value was independent of other covariates, and regardless of the presence or not of anaemia. Importantly, the addition of red cell distribution width to the clinical risk model for the prediction of death or hospitalization for heart failure at 1 year had a significant integrated discrimination improvement of 33% (P<.001) and a net reclassification improvement of 10.3% (P=.001).Conclusions
Red cell distribution width is an independent risk marker and adds prognostic information in outpatients with chronic heart failure. These findings suggest that this biological measurement should be included in the management of these patients.Full English text available from:www.revespcardiol.org 相似文献85.
Cathy Steel Allison Golden Joseph Kubofcik Nicole LaRue Tala de los Santos Gonzalo J. Domingo Thomas B. Nutman 《Clinical and Vaccine Immunology : CVI》2013,20(8):1155-1161
The Global Programme to Eliminate Lymphatic Filariasis has an urgent need for rapid assays to detect ongoing transmission of lymphatic filariasis (LF) following multiple rounds of mass drug administration (MDA). Current WHO guidelines support using the antigen card immunochromatographic test (ICT), which detects active filarial infection but does not detect early exposure to LF. Recent studies found that antibody-based assays better serve this function. In the present study, two tests, a rapid IgG4 enzyme-linked immunosorbent assay (ELISA) and a lateral-flow strip immunoassay, were developed based on the highly sensitive and specific Wuchereria bancrofti antigen Wb123. A comparison of W. bancrofti-infected and -uninfected patients (with or without other helminth infections) demonstrated that both tests had high sensitivities and specificities (93 and 97% [ELISA] and 92 and 96% [strips], respectively). When the W. bancrofti-uninfected group was separated into those with other filarial/helminth infections (i.e., onchocerciasis, loiasis, and strongyloidiasis) and those who were parasite uninfected, the specificities of the assays varied between 91 and 100%. In addition, the geometric mean response by ELISA of W. bancrofti-infected patients was significantly higher than the response of those without W. bancrofti infection (P < 0.0001). Furthermore, the Wb123 ELISA and the lateral-flow strips had high positive and negative predictive values, giving valuable information on the size of survey population needed to be reasonably certain whether or not transmission is ongoing. These highly sensitive and specific IgG4 tests to the W. bancrofti Wb123 protein give every indication that they will serve as useful tools for post-MDA monitoring. 相似文献
86.
87.
Beatriz Domínguez‐Gil Elisabeth Coll Mario Fernndez‐Ruiz Esther Corral Francisco del Río Rafael Zaragoza Juan J. Rubio Domingo Hernndez 《American journal of transplantation》2020,20(9):2593-2598
Spain has been one of the most affected countries by the COVID‐19 outbreak. As of April 28, 2020, the number of confirmed cases is 210 773, including 102 548 patients recovered, more than 10 300 admitted to the ICU, and 23 822 deaths, with a global case fatality rate of 11.3%. From the perspective of donation and transplantation, the Spanish system first focused on safety issues, providing recommendations for donor evaluation and testing, and to rule out SARS‐CoV‐2 infection in potential recipients prior to transplantation. Since the country entered into an epidemiological scenario of sustained community transmission and saturation of intensive care, developing donation and transplantation procedures has become highly complex. Since the national state of alarm was declared in Spain on March 13, 2020, the mean number of donors has declined from 7.2 to 1.2 per day, and the mean number of transplants from 16.1 to 2.1 per day. Increased mortality on the waiting list may become a collateral damage of this terrible pandemic. 相似文献
88.
JL Adams M Murray N Patel MT Sawkin RC Boardman C Pham H Kaur D Patel JL Yager L Pontiggia J Baxter 《HIV medicine》2021,22(1):28-36
89.
Ana Lucena-Valera Domingo Perez-Palacios Rocio Mu oz-Hernandez Manuel Romero-G mez Javier Ampuero 《World journal of hepatology》2021,13(6):634-649
Wilson's disease(WD) is a rare condition caused by copper accumulation primarily in the liver and secondly in other organs, such as the central nervous system. It is a hereditary autosomal recessive disease caused by a deficiency in the ATP7 B transporter. This protein facilitates the incorporation of copper into ceruloplasmin. More than 800 mutations associated with WD have been described. The onset of the disease frequently includes manifestations related to the liver(as chronic liver disease or acute liver failure) and neurological symptoms, although it can sometimes be asymptomatic. Despite it being more frequent in young people, WD has been described in all life stages. Due to its fatal prognosis, WD should be suspected in all patients with unexplained biochemical liver abnormalities or neurological or psychiatric symptoms. The diagnosis is established with a combination of clinical signs and tests, including the measurement of ceruloplasmin, urinary copper excretion, copper quantification in liver biopsy, or genetic assessment. The pharmacological therapies include chelating drugs, such as D-penicillamine or trientine, and zinc salts, which are able to change the natural history of the disease, increasing the survival of these patients. In some cases of end-stage liver disease or acute liver failure, liver transplantation must be an option to increase survival. In this narrative review, we offer an overview of WD, focusing on the importance of clinical suspicion, the correct diagnosis, and treatment. 相似文献
90.
巨噬细胞迁移抑制因子最初是由于能抑制体外巨噬细胞随机迁移而被发现,现在它作为一种重要的调节因子参与一系列炎症性疾病过程.我们最近发现,巨噬细胞迁移抑制因子的缺失使一些由炎症介质诱发的白细胞-内皮细胞相互作用减弱,提示巨噬细胞迁移抑制因子在炎症反应中起作用的机制之一是促进白细胞聚集.…… 相似文献